Troy Wuertz
@Ikarian Capital, Llc
Latest period2024 - Q3ReportedManaged Assets$717.154MTotal holdings121
Assets growth rate24.93%Assets growth rate (2-Q avg)-6.06%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Ikarian Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 121 positions.
Assets under management
The assets under management (AUM) of Ikarian Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 717.154M in assets, with a quarterly growth rate of 24.93% and a 2-quarter average growth rate of -6.06%. The portfolio is managed by Troy Wuertz, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
VRNAVerona Pharma Plc
| 0% | $2.908M 201,116 shares@ $14.47 avg price | Exited |
QTTBQ32 Bio Inc
| 0% | $1.958M 109,094 shares@ $17.95 avg price | Exited |
ANNXAnnexon Inc
| 0% | $1.862M 380,000 shares@ $4.9 avg price | Exited |
BCLIBrainstorm Cell Therapeutics
| 0% | $30,547 90,242 shares@ $0.34 avg price | Exited |